Sms Pharmaceuticals Q4 Results
- BSE: 532815
- NSE: SMSPHARMA
- ISIN: INE812G01025
- Sector: Biotechnology & Drugs
BSE
253.50
-0.60 (-0.24%)
-0.60 (-0.24%)Volume7.91 K
Updated: Fri 13 Jun, 2025 | 15:29:58
NSE
252.00-3.95 (-1.54%)
-3.95 (-1.54%)Volume1.05 L
Updated: Fri 13 Jun, 2025 | 15:29:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹248.20 Cr.(0.98%)
- Operating Profit₹32.17 Cr.(25.15%)
- Profit After Tax₹20.32 Cr.(17.57%)
- Operating Margin12.96%(23.94%)
Note: Comparison is on YoY basis
Quarterly - Sms Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 248.20 | 173.35 | 43.17% | 245.80 | 0.98% |
| Selling/ General/ Admin Expenses Total | 26.63 | 18.64 | 42.83% | 22.93 | 16.12% |
| Depreciation/ Amortization | 8.64 | 8.70 | -0.64% | 7.92 | 9.14% |
| Other Operating Expenses Total | 7.44 | 15.26 | -51.24% | 6.70 | 11.06% |
| Total Operating Expense | 216.03 | 148.84 | 45.14% | 220.10 | -1.85% |
| Operating Income | 32.17 | 24.51 | 31.22% | 25.70 | 25.15% |
| Net Income Before Taxes | 28.52 | 22.44 | 27.12% | 21.74 | 31.22% |
| Net Income | 20.32 | 18.24 | 11.37% | 17.28 | 17.57% |
| Diluted Normalized EPS | 2.40 | 2.15 | 11.63% | 2.05 | 17.14% |